Concentrix Corporation is projected to report fourth quarter earnings of $2.91 per share when it releases results before the market opens on Tuesday, January 13, 2025, representing a decline from $3.26 per share in the same period a year ago. Revenue is expected to rise to $2.54 billion, up from $2.45 billion in Q4 of 2023, according to Benzinga Pro data. The forecast follows a disappointing Q3 report on September 25, when Concentrix missed earnings expectations and provided subdued guidance for the current quarter.

In the run-up to the call, top-performing analysts have largely maintained bullish stances while trimming targets. Barrington Research’s Vincent Colicchio reaffirmed an Outperform rating with a $62 price target on November 20, 2025, reflecting his 58% accuracy. Robert W. Baird’s David Koning held an Outperform rating but lowered his target from $75 to $62 on September 29, 2025; his accuracy stands at 72%. Canaccord Genuity’s Joseph Vafi retained a Buy rating and an $80 target on September 23, 2025, boasting a 75% accuracy rate. Bank of America Securities’ Ruplu Bhattacharya maintained a Neutral rating and cut the target from $65 to $61 on June 27, 2025, with a 68% accuracy record.

CEO Christopher A. Caldwell increased his stake by acquiring 1,000 shares at an average cost of $40.00 on October 31, boosting his holding to 287,661 shares valued at approximately $11.5 million. Insiders have purchased 4,000 shares valued at $169,410 over the past 90 days, accounting for 3.20% of total shares outstanding. Major institutional investors control 90.34% of the float, led by AQR Capital Management with 4.3 million shares (up 25.5% in Q2), Arrowstreet Capital with 535,843 shares (up 247.2%), and new stakes from Deprince Race & Zollo, Norges Bank, and Capital Management Corp VA totaling over $72 million combined.